Qube Research & Technologies (QRT)
IMNM icon

Qube Research & Technologies (QRT)’s Immunome IMNM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.12M Buy
+188,229
New +$4.19M ﹤0.01% 1766
2025
Q4 		– Sell
-25,217
Closed -$295K – 3859
2025
Q3 		$295K Buy
+25,217
New +$251K ﹤0.01% 2854
2025
Q1 		– Sell
-107,794
Closed -$1.14M – 3669
2024
Q4 		$1.14M Sell
107,794
-51,016
-32% -$616K ﹤0.01% 2116
2024
Q3 		$2.32M Sell
158,810
-234,592
-60% -$3.33M ﹤0.01% 1708
2024
Q2 		$4.76M Sell
393,402
-137,060
-26% -$2.14M 0.01% 1278
2024
Q1 		$13.1M Buy
530,462
+326,914
+161% +$6.63M 0.02% 731
2023
Q4 		$2.18M Buy
203,548
+203,538
+2,035,380% +$1.69M ﹤0.01% 1491
2023
Q3 		$84 Buy
+10
New +$73 ﹤0.01% 3777

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMNM Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Immunome (IMNM) in Q1 2026: 188,229 shares worth $4.12M. The stake represents ﹤0.01% of the portfolio and ranks #1766 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IMNM as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in IMNM in Q3 2023 and has held it in 8 quarters since. The position peaked at $13.1M in Q1 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Qube Research & Technologies (QRT) held 188,229 shares of Immunome worth $4.12M as of Q1 2026.
  • Immunome was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Immunome made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1766 holding.
  • Qube Research & Technologies (QRT) first reported a position in Immunome in Q3 2023 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Immunome position peaked at $13.1M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.